| Factor Information | |
|---|---|
| Data ID | 3982 |
| Factor | prevalence of CHD in live births |
| Description | The prevalence of CHD in live births is 10.5‰ (131/12 402) based on the present available data |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | mobidity assessment |
| Objective | To investigate the associations of parental periconceptional nutritional factors with CHD. |
| Conclusion | The prevalence of CHD in live births is 10.5‰ (131/12 402) based on the present available data. Approximately 20.0% of preconception women and 44.9% of early-pregnancy women had red blood cell (RBC) folate levels that met the international recommendation for preventing neural tube defects. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 31767384 |
| Year | 2019 |
| Title | Risk of coronary artery disease in adults with congenital heart disease: A comparison with the general population |
| Sample | ||
|---|---|---|
| Population | infants | |
| Source | patients of CHD | |
| Region | Shanghai, China | |
| Method | questionnaires | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD in live births(Treatment) | N/A(Control) |
| Number | 131 | N/A |
| Age | 29.9±4.0 years | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 10.5‰ | N/A |
